ACS Current Treatment

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/35

encourage image

There's no tags or description

Looks like no tags are added yet.

36 Terms

1
New cards

The ACC/AHA guidelines continue to emphasize the importance of primary prevention of ACS by decreasing:

-CAD risk factors such as HTN, hypercholesterolemia, DM, smoking

-family history of CAD is also a risk factor

2
New cards

Atherosclerotic risk factors score calculators:

Framingham risk score

Pooled Cohort Equations

3
New cards

At the individual level, patients should be advised to do what at first recognition of ACS symptoms

chew a nonenteric coated aspirin (162 to 325 mg)

4
New cards

Electrocardiographic findings that may reflect myocardial ischemia include changes in what?

the PR segment, QRS complex, and the ST segment.1

5
New cards

_______is the recommended reperfusion method

Primary percutaneous coronary intervention (PCI)

6
New cards

The goal of medical management is to administer fibrinolytic therapy within _____ minutes

30

7
New cards

_______ is highly recommended in the treatment of STEMI to support primary PCI and fibrinolytic treatment strategies

Dual antiplatelet therapy

8
New cards

For patients undergoing primary PCI for STEMI, what should be given as early as possible?

clopidogrel 600 mg

9
New cards

When a patient has a stent, what should be given to them?

75 mg clopidogrel

10
New cards

Loading dose for clopidogrel requirements with PCI:

Should receive a loading dose of

clopidogrel 300 mg in persons younger than 75 years, or

75 mg in persons 75 years and older before treatment

11
New cards

In patients receiving fibrinolytic treatment, how should clopidogrel be given?

Clopidogrel, 75 mg per day, should be continued in patients receiving fibrinolytic treatment for at least 14 days and up to one year

12
New cards

Aggrastat

tirofiban

13
New cards

Integrilin

eptifibatide

14
New cards

Reopro

abciximab

15
New cards

Triple ____ therapy as been associated with an increased risk of bleeding

antiplatelet

16
New cards

_______ should also be initiated with either PCI or fibrinolytic therapy for the treatment of STEMI.

anticoagulation therapy

17
New cards

For patients undergoing PCI, ______ should be administered to maintain a therapeutic activated clotting time level.

unfractionated heparin or bivalirudin

18
New cards

________ should not be used as sole anticoagulation therapy in patients undergoing PCI because of the risk of catheter thrombosis

Fondaparinux (Arixtra)

19
New cards

For patients receiving fibrinolytic therapy for STEMI, _______ can be used as anticoagulation

Unfractionated heparin, enoxaparin (Lovenox), or fondaparinux can be used.

20
New cards

Treatment should be given for a minimum of _____and up to ______

48 hours and up to 8 days

21
New cards

Additional acute treatment options for ACS:

supplemental oxygen, nitroglycerin, intravenous morphine, beta blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and statins

22
New cards

When should oxygen saturation be appropriate?

when oxygen sat is less than 90%

23
New cards

What is the medication of choice for pain relief in STEMI patients?

morphine

24
New cards

_______ should be started within 24 hours in patients with STEMI or NSTE-ACS who do not have signs of heart failure, evidence of low output state, increased risk of cardiogenic shock, or other contraindications.

beta blockers

25
New cards

________ should be administered within the first 24 hours to all patients with heart failure, STEMI with anterior location, or ejection fraction less than 40%, in the absence of contraindications to therapy

Angiotensin-converting enzyme inhibitors

26
New cards

Continuing or initiating high-intensity statin therapy is recommended, even in patients with baseline low-density lipoprotein cholesterol levels less than ____

70 mg/dL

27
New cards

Lovenox dosing for fibrinolytic therapy:

If younger than 75 years: 30 mg IV bolus, followed in 15 minutes by 1 mg per kg subcutaneously every 12 hours (maximum 100 mg for the first two doses)

If 75 years or older: no bolus; 0.75 mg per kg subcutaneously every 12 hours (maximum 75 mg for the first two doses).

Regardless of age, if creatinine clearance < 30 mL per minute per 1.73 m2, 1 mg per kg subcutaneously every 24 hours

For the index hospitalization, continue up to eight days or until revascularization

28
New cards

Carvedilol dose for STEMI:

6.25 mg twice daily, titrate up to 25 mg as tolerated

29
New cards

Metoprolol IV dose STEMI:

5 mg every five minutes as tolerated, up to three doses

30
New cards

Metoprolol oral dose:

25 to 50 mg every six to 12 hours, eventually transitioning to twice daily or daily

31
New cards

Contraindications for beta blockers:

Contraindications to beta-blocker therapy include signs of heart failure, low output state, and risk of cardiogenic shock

32
New cards

Lisinopril dose ACS:

2.5 to 5 mg per day, titrate up to 10 mg as tolerated

33
New cards

The recommended goals for first medical contact to device time are _____ minutes for persons presenting to a PCI-capable hospital and ______ minutes for those presenting to a non-PCI-capable facility.

90

120

34
New cards

Fibronolytic therapy should be given to patients at a non-PCI facility if the time to PCI hospital exceeds what?

120 minutes

35
New cards

Evidence of failed reperfusion includes lack of resolution of what?

ST elevation and persistent or recurrent chest pain.

36
New cards

Absolute contraindications for fibrinolytic therapy patients with STEMI:

Any prior ICH

Known structural cerebral vascular lesion (e.g., arteriovenous malformation)

Known malignant intracranial neoplasm (primary or metastatic)

Ischemic stroke within three months, except acute ischemic stroke within 4.5 hours

Suspected aortic dissection

Active bleeding or bleeding diathesis (excluding menses)

Significant closed-head or facial trauma within three months

Intracranial or intraspinal surgery within two months Severe uncontrolled hypertension (unresponsive to emergency therapy)

For streptokinase, treatment within the previous six months